Editas Medicine GAAP EPS of -$0.92 misses by $0.35, revenue of $4.66M beats by $3.95M
Source: SeekingAlpha
2025-05-12 16:35:13 ET
More on Editas Medicine
- Editas Medicine: Do The Risks Outweigh The Rewards?
- Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript)
- Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript)
- Editas Medicine Q1 2025 Earnings Preview
- Editas Medicine GAAP EPS of -$0.55 misses by $0.20, revenue of $30.6M misses by $6.57M
Read the full article on Seeking Alpha
For further details see:
Editas Medicine GAAP EPS of -$0.92 misses by $0.35, revenue of $4.66M beats by $3.95M
Editas Medicine Inc.
NASDAQ: EDIT
EDIT Trading
-2.57% G/L:
$2.465 Last:
588,093 Volume:
$2.60 Open:
EDIT Latest News
March 09, 2026 07:00:00 am
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
EDIT Stock Data
$174,737,401
95,568,668
0.4%
71
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
